Hyundai Pharmaceutical Co., Ltd. (004310.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 95.79B |
| Enterprise Value | 143.35B |
| P/E Ratio | 29.1 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 0.63 |
| Price/Book Ratio | 0.91 |
| Enterprise/Revenue | 0.79 |
| Enterprise/EBITDA | 13.48 |
Fiscal Year
| Fiscal Year | November 30, 2025 |
| Most Recent Quarter | February 28, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 191.79B |
| Revenue/Share | 7,446.52 |
| Gross Profit | 78.23B |
| EBITDA | 7.58B |
| Net Income | 2.52B |
| Diluted EPS | 96.28 |
Balance Sheet
| Total Cash | 18.67B |
| Total Cash/Share | 712.27 |
| Total Debt | 50.12B |
| Total Debt/Equity | 0.37 |
| Current Ratio | 1.28 |
| Book Value Per Share | 5,143.92 |
Price History
| 52-Week Change | 31.69 |
| 52-Week High | 15,960 |
| 52-Week Low | 3,480 |
| Moving Average 50 Days | 6,873.3 |
| Moving Average 200 Days | 7,501.6 |
Statistics
| Average Volume | 2.56M |
| Shares Outstanding | 26.14M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 30 |
| Trailing Annual Dividend Yield | 0.64 |
| Payout Ratio | 0.19 |
| Last Split Factor | 513:500 |
| Last Split Date | October 20, 2017 |
AD
